|
1
|
Sistema de estabilidad de 2-Pr, USP, S/M
|
HC LEGD GROUP S.A.C.
|
N/A
|
2025-10-30
|
UNITED STATES
|
0.03 Kgs
|
1 KG
|
|
2
|
Parbendazol (Vial x 200 mg), USP, S/M
|
HC LEGD GROUP S.A.C.
|
N/A
|
2025-10-30
|
CHINA
|
0.07 Kgs
|
3 KG
|
|
3
|
Claritromicina Identidad (Vial, USP, S/M
|
HC LEGD GROUP S.A.C.
|
N/A
|
2025-10-30
|
INDIA
|
0.2 Kgs
|
3 KG
|
|
4
|
Ceftriaxona Sodica E-Isomero, USP, S/M
|
HC LEGD GROUP S.A.C.
|
N/A
|
2025-10-30
|
INDIA
|
0.08 Kgs
|
1 KG
|
|
5
|
Metilparabeno (Vial x 125 mg), USP, S/M
|
HC LEGD GROUP S.A.C.
|
N/A
|
2025-10-30
|
JAPAN
|
0.02 Kgs
|
1 KG
|
|
6
|
Claritromicina Compuesto Relac, USP, S/M
|
HC LEGD GROUP S.A.C.
|
N/A
|
2025-10-30
|
UNITED STATES
|
0.13 Kgs
|
2 KG
|
|
7
|
Estßndar de verificaci¾n, USP, S/M
|
HC LEGD GROUP S.A.C.
|
N/A
|
2025-10-30
|
SPAIN
|
0.08 Kgs
|
3 KG
|
|
8
|
ORFENADRINA COMPUESTO RELACIONADO C (VIAL X 20 MG), USP, S/M
|
HC LEGD GROUP S.A.C.
|
N/A
|
2025-10-18
|
INDIA
|
0.06 Kgs
|
1 KG
|
|
9
|
LIDOCAINA CLORHIDRATO (VIAL X 150 MG), USP, S/M
|
HC LEGD GROUP S.A.C.
|
N/A
|
2025-10-18
|
SWEDEN
|
0.02 Kgs
|
1 KG
|
|
10
|
OCTISALATO (VIAL X 400 MG), USP, S/M
|
HC LEGD GROUP S.A.C.
|
N/A
|
2025-10-18
|
UNITED STATES
|
0.02 Kgs
|
1 KG
|